Literature DB >> 12235189

The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS.

John W Newman1, Takaho Watanabe, Bruce D Hammock.   

Abstract

A method for the simultaneous quantification of urinary linoleic and arachidonic acid derived epoxides and diols, as well as the arachidonate omega hydroxylated product has been developed. The method employs negative mode electrospray ionization and HPLC with tandem mass spectroscopy for quantification. Odd chain length saturated epoxy and dihydroxy fatty acids are used as analytical surrogates resulting in linear calibrations (r (2) > or = 0.9995). Standard addition analyses showed that matrix effects do not prevent these surrogates from yielding reliable quantitative results. Using 4 ml urine aliquots at a final extract volume of 100 micro l and injecting 10 micro l, method detection limits and limits of quantification were < or =0.5 and 1.5 nM, respectively. The sensitivity for dihydroxy lipids was from 3- to 10-fold greater than the corresponding epoxy fatty acid. Shot to shot run times of 31 min were achieved. Rodent and human urine analyses indicated the method sensitivity is sufficient for general research applications. In addition, diurnal fluctuations in linoleate and arachidonate derived metabolites were observed in human subjects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235189     DOI: 10.1194/jlr.d200018-jlr200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  65 in total

1.  An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.

Authors:  John D Imig; Xueying Zhao; Constantine Z Zaharis; Jeffrey J Olearczyk; David M Pollock; John W Newman; In-Hae Kim; Takaho Watanabe; Bruce D Hammock
Journal:  Hypertension       Date:  2005-09-12       Impact factor: 10.190

2.  Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Craig R Lee; Kari E North; Molly S Bray; Myriam Fornage; John M Seubert; John W Newman; Bruce D Hammock; David J Couper; Gerardo Heiss; Darryl C Zeldin
Journal:  Hum Mol Genet       Date:  2006-04-04       Impact factor: 6.150

3.  Metabolomics: building on a century of biochemistry to guide human health.

Authors:  J Bruce German; Bruce D Hammock; Steven M Watkins
Journal:  Metabolomics       Date:  2005-03       Impact factor: 4.290

Review 4.  Mass spectrometry-based metabolomics.

Authors:  Katja Dettmer; Pavel A Aronov; Bruce D Hammock
Journal:  Mass Spectrom Rev       Date:  2007 Jan-Feb       Impact factor: 10.946

5.  Plasma 15-Hydroxyeicosatetraenoic Acid Predicts Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease.

Authors:  Elina Jerschow; Matthew L Edin; Teresa Pelletier; Waleed M Abuzeid; Nadeem A Akbar; Marc Gibber; Marvin Fried; Fred B Lih; Artiom Gruzdev; J Alyce Bradbury; Weiguo Han; Golda Hudes; Taha Keskin; Victor L Schuster; Simon Spivack; Darryl C Zeldin; David Rosenstreich
Journal:  J Allergy Clin Immunol Pract       Date:  2017-01-31

6.  An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.

Authors:  Anne M Dorrance; Nicole Rupp; David M Pollock; John W Newman; Bruce D Hammock; John D Imig
Journal:  J Cardiovasc Pharmacol       Date:  2005-12       Impact factor: 3.105

Review 7.  Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids.

Authors:  Giuseppe Astarita; Alexandra C Kendall; Edward A Dennis; Anna Nicolaou
Journal:  Biochim Biophys Acta       Date:  2014-12-05

8.  Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

Authors:  Jeffrey J Olearczyk; Jeffrey E Quigley; Bradford C Mitchell; Tatsuo Yamamoto; In-Hae Kim; John W Newman; Ayala Luria; Bruce D Hammock; John D Imig
Journal:  Clin Sci (Lond)       Date:  2009-01       Impact factor: 6.124

9.  Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.

Authors:  Kimberly L Fife; Yingmei Liu; Kara R Schmelzer; Hsing-Ju Tsai; In-Hae Kim; Christophe Morisseau; Bruce D Hammock; Deanna L Kroetz
Journal:  J Pharmacol Exp Ther       Date:  2008-09-24       Impact factor: 4.030

10.  Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression.

Authors:  Christoph F A Vogel; Wen Li; Eric Sciullo; John Newman; Bruce Hammock; J Rachel Reader; Joseph Tuscano; Fumio Matsumura
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.